Form D · Biotechnology
Chimeros Inc
San Diego, CA · CIK 0001340917
Offering snapshot reported Aug 10, 2011 · SEC filing
- Reported sold
- $375K Offering amount: $375K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 1, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2011 | Initial | $375,000 | No comparison | 2 | SEC filing |
| Aug 10, 2011 | Initial | $760,945 | No comparison | 1 | SEC filing |
| Apr 13, 2011 | Initial | $600,000 | No comparison | 5 | SEC filing |
| Dec 3, 2010 | Initial | $750,000 | No comparison | 11 | SEC filing |
| Oct 28, 2010 | Amendment | $433,537 | $289,025vs Jul 20, 2010 | 15 | SEC filing |
| Jul 20, 2010 | Initial | $144,512 | No comparison | 15 | SEC filing |
| Apr 8, 2010 | Initial | $444,081 | No comparison | 16 | SEC filing |
| Oct 9, 2009 | Initial | $611,246 | No comparison | 1 | SEC filing |
| Jan 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 15, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 10, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 3, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 18, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 27, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 6, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-164230
Source: Form D, filed Aug 10, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alex Barkas, Ph.D. | Director |
| Miguel De Los Rios | Director, Executive |
| Miguel De Los Rios, Ph.D. | Director, Executive |
| Frank Fosoter | Director |
| Frank Foster | Director |
| David Lockhart | Director |
| David J. Lockhart, Ph.D. | Director |
| John Mendlein | Director |
| John Mendlein, Ph.D. | Director |
| Stephen Watkins | Director |
| Ilan Zipkin | Director |
| Ilan D. Zipkin, Ph.D. | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3030 Bunker Hill Street Suite 102
San Diego, CA, 92109-5754
San Diego, CA, 92109-5754